Gore REVISE Study Receives Approval From FDA
07 April 2008
- The Gore REVISE Study is a randomized, multi-center clinical trial intended to establish efficacy and safety of the GORE VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface to revise arterio-venous grafts at the venous anastomosis in hemodialysis patients.
GORE® C3 Delivery System Approved In Japan
03 December 2013
- System Enables Physicians and Interventionalists to Reposition GORE® EXCLUDER® AAA Endoprosthesis for Ideal Placement in Treating Abdominal Aortic Aneurysms
Gore REVISE Study Receives Conditional Approval From FDA
12 July 2007
- Conditional approval to proceed with the Gore REVISE (VasculaR
ision with GORE VI
thesis vs PercutanE
ous Transluminal Angioplasty) Study was announced today by W. L. Gore & Associates.